<?xml version="1.0" encoding="UTF-8"?>
<ref id="B283-pharmaceuticals-12-00147">
 <label>283.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Smallwood</surname>
    <given-names>H.S.</given-names>
   </name>
   <name>
    <surname>Duan</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Morfouace</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Rezinciuc</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Shulkin</surname>
    <given-names>B.L.</given-names>
   </name>
   <name>
    <surname>Shelat</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Zink</surname>
    <given-names>E.E.</given-names>
   </name>
   <name>
    <surname>Milasta</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Bajracharya</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Oluwaseum</surname>
    <given-names>A.J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Targeting Metabolic Reprogramming by Influenza Infection for Therapeutic Intervention</article-title>
  <source>Cell Rep.</source>
  <year>2017</year>
  <volume>19</volume>
  <fpage>1640</fpage>
  <lpage>1653</lpage>
  <pub-id pub-id-type="doi">10.1016/j.celrep.2017.04.039</pub-id>
  <pub-id pub-id-type="pmid">28538182</pub-id>
 </element-citation>
</ref>
